Remicade (Infliximab) Injection

Description

Remicade is approved for treating the following conditions, typically when other conventional therapies have been inadequate or poorly tolerated:

• Crohn’s Disease: For moderate to severe active Crohn’s disease, including fistulizing disease (abnormal connections between the gut and other organs).
• Ulcerative Colitis: For moderate to severe active ulcerative colitis.
• Rheumatoid Arthritis: Used in combination with methotrexate to reduce symptoms, improve physical function, and slow the progression of joint damage.
• Ankylosing Spondylitis: To relieve inflammation and stiffness in the joints of the spine.
• Psoriatic Arthritis: To reduce joint pain and swelling and inhibit the progression of joint damage in active and progressive cases.
• Psoriasis: For adults with chronic, severe plaque psoriasis.

Which areas or states do you supply to?

Remicade (Infliximab) Injection is available in following cities in India – Mumbai, Delhi, Gurgaon, Noida, Bengaluru, Hyderabad, Ahmedabad, Chennai, Kolkata, Surat, Pune, Jaipur, Lucknow, Kanpur, Gurgaon, Punjab, Nagpur, Indore, Thane, Bhopal, Visakhapatnam, Pimpri-Chinchwad, Patna, Vadodara, Ghaziabad, Ludhiana, Agra, Nashik, Faridabad, Meerut, Rajkot, Kalyan-Dombivli, Vasai-Virar, Varanasi, Srinagar, Aurangabad, Dhanbad, Amritsar, Navi Mumbai, Prayagraj, Howrah, Ranchi, Jabalpur, Gwalior, Coimbatore, Vijayawada, Jodhpur, Madurai, Raipur, Kota, etc.

For large institutional or inter-state distribution, please contact our sales department for region-specific arrangements.